Navigation Links
Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
Date:4/23/2012

FARMINGTON, Conn., April 23, 2012 /PRNewswire-iReach/ -- Global Information Inc. is announces limited time remaining to purchase Early Bird discounted registration for three important Boston healthcare conferences:

Next-Gen Kinase Inhibitors 2012

Pioneers from across the rapidly maturing kinase inhibitors field will gather to explore the exciting question of what lies ahead at the Next-Gen Kinase Inhibitors Conference in Cambridge, MA. What is in store for the pharmaceutical industry and what new avenues are opening up for new technologies and methods as novel targets and therapeutic approaches are explored? What ground-breaking kinase indications are being discovered, and what other therapeutic areas are blossoming? Topics include key issues around addressing resistance; selectivity versus safety; developing lead compounds; the integration of chemistry and biology, and much more.

Save up to $200 by registering before April 27! Additional information and Early Bird discounted rates are available at http://www.giiconference.com/chi214653-2012/

Structure-Based Drug Design Conference 2012

Structure-based drug design took nearly two decades of multiple, parallel technological improvements to arrive at its current mainstream position in medicinal chemistry. At the 12th Annual Structure-Based Drug Design Conference in Cambridge, MA an accomplished faculty of experts will bring to focus recent advancements in this evolving and dynamic field. Attendees will learn about developments in computer graphics, high-power radiation sources, computational processing power, refinement protocols, virtual screening and crystallography, all technolgies that are absolutely necessary to create the environment for rapid, iterative structure-based drug discovery.

Save up to $200 by registering before April 27! Additional information and Early Bird discounted rates are available at http://www.giiconference.com/woco224416-2012/

mHealth World Congress 2012

Mobile health (mHealth) is a revolution, changing everything in the healthcare industry from the way consumers engage in healthy behaviors to the way patients manage their care; from how physicians manage their practices to payers interact with their members. Thousands of apps for smartphones and sophisticated health monitoring tools have been developed to not only improve efficiency for care management, but also open up new lines of communication between physicians and their patients and colleagues.

The 4th Annual mHealth World Congress 2012 in Boston, July 25-27, gathers international health care and technology executives to discuss the latest applications and strategic initiatives for mobile technologies as they transform the future of health care. Over two days attendees will have the opportunity to engage in keynote presentations, debates, summits, case studies, and innovation trend forums to hear from healthcare providers, health plans, developers, employers manufacturers, and distributors on the opportunities and the sustainable business models being rapidly deployed that are changing access and delivery of care.

Save up to $800 by registering before May 18! Additional information and Early Bird discounted rates are available at http://www.giiconference.com/woco224424-2012/

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Chemist to donate potential pharmaceutical royalties to Madagascar
2. Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology
3. Anadys Pharmaceuticals to Present at the Roth OC Growth Stock Conference
4. Simulating pharmaceutical and personal care product transport
5. Researchers prolong the half-life of biopharmaceutical proteins
6. InVivo and CEVEC pharmaceuticals sign license agreement regarding the use of human CAP-T Technology for production of recombinant proteins
7. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
8. TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services
9. NIH awards $8.5 million for research on pharmaceuticals for children
10. Biostar Pharmaceuticals, Inc. Receives New Advertising Approval from Shaanxi SFDA for Marketing Xin Aoxing Capsule
11. ACS Green Chemistry Institute Pharmaceutical Roundtable award goes to Scottish chemist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology: